Taubman To Chair Department Of Medicine
May 14, 2007
Mark B. Taubman, M.D.
A national search for a new chairman of Medicine at the University of Rochester School of Medicine and Dentistry has led to the selection of Mark B. Taubman, M.D., the School’s current chief of Cardiology. The appointment is expected to be approved at the next meeting of the University of Rochester trustees.
Effective May 1, 2007, Taubman began serving as chairman and Charles E. Dewey professor of Medicine, overseeing the single largest department within the Medical School. He will also continue serving as director of the Cardiovascular Research Institute. According to the Surgery chair Jeffrey H. Peters, M.D., who led the search process, Taubman’s selection was a natural choice for the search committee.
“URMC searched wide and hard for our new chief of medicine, and carefully considered some of the best candidates in the USA,” Peters said. “After nearly 9 months of effort, in the end the search committee felt strongly and unanimously that we had the right mix of leadership, skill, talent and humanism in one of our own – Dr. Mark Taubman.”
“Mark is an accomplished researcher, clinician, and educator, nationally recognized in all three areas,” said School of Medicine and Dentistry dean David S. Guzick, M.D., Ph.D. “He has the knowledge, experience, personality, drive, and depth of commitment to be a stellar chair of Medicine.”
Taubman joined the University of Rochester as chief of Cardiology in 2003 from Mount Sinai School of Medicine and is credited with significantly advancing that school’s M.D.-Ph.D. program. Since Taubman took over leadership of Cardiology, overall funding for research in the unit has increased by 11.8 percent, going from $8.5 million to $9.5 million by the end of 2006. Overall research funding figures are comprised of grants from the National Institutes of Health, funding from the pharmaceutical industry to conduct clinical trials of new treatments and funding from disease-specific foundations. Taubman has more than 110 journal articles, book chapters, and other publications to his credit.
He’s also been the guiding force behind the expansion of cardiac patient care services, faculty recruitment, strengthening treatments for those with heart arrhythmias and heart failure, adding new preventive cardiology programs such as the women’s heart program, and forging strong regional services. Last December, Taubman was named editor-in-chief of Arteriosclerosis, Thrombosis and Vascular Biology, one of five international medical journals published by the American Heart Association, and the leading journal in the field of vascular biology.
“The Department of Medicine at the University of Rochester has a storied history,” Taubman said. “I am honored and delighted to be the next in what has been a list of outstanding academic Medicine chairs. The launch of the new Medical Center strategic plan and the Clinical and Translational Medicine Institute make this a particularly exciting time to be at the helm of the department and will provide unprecedented growth opportunities.”
Taubman is a graduate of the New York University School of Medicine who interned at Peter Bent Brigham Hospital before completing his Medicine residency and cardiology fellowship training at the Brigham & Women’s Hospital. He held academic appointments at Harvard Medical School, Boston’s Children’s Hospital Medical Center, and Mt. Sinai School of Medicine prior to being recruited to the University of Rochester.
As chair of Medicine, Taubman succeeds Berk, who became senior vice president for Health Sciences and CEO of the Medical Center and Strong Health last August.
“Mark has clearly earned the respect of his colleagues within the Department of Medicine and across the country. He is a brilliant scientist, skilled administrator and an accomplished clinician and teacher,” said Bradford C. Berk, M.D., Ph.D., Medical Center CEO. “He is the ideal person to lead the department and help URMC take full advantage of the opportunities that lie ahead.”